Validating posttransplant hepatocellular carcinoma recurrence data in the united network for organ sharing database-Reference-Cited by-同舟云学术

Validating posttransplant hepatocellular carcinoma recurrence data in the united network for organ sharing database

Published:2013-10-21 Issue:12 Volume:19 Page:1318-1323
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Samoylova Mariya L.¹,Dodge Jennifer L.¹,Vittinghoff Eric²,Yao Francis Y.¹³,Roberts John Paul¹

Affiliation:

1. Department of Surgery; University of California San Francisco; San Francisco CA

2. Department of Epidemiology and Biostatistics; University of California San Francisco; San Francisco CA

3. Department of Medicine; University of California San Francisco; San Francisco CA

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Reference12 articles.

1. Organ Procurement and Transplantation Network OPTN policy 7.0. Data submission requirements http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs/policy_23.pdf 2013

2. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma;Wald;Radiology,2013

3. Linking the US transplant registry to administrative claims data: expanding the potential of transplant research;Gilmore;Med Care,2007

4. Database comparison of the Adult-To-Adult Living Donor Liver Transplantation Cohort Study (A2ALL) and the SRTR U.S. Transplant Registry;Gillespie;Am J Transplant,2010

5. Outcomes of adult living donor liver transplantation: comparison of the Adult-to-Adult Living Donor Liver Transplantation Cohort Study and the national experience;Olthoff;Liver Transpl,2011

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation;BMC Gastroenterology;2024-02-26

2. Transplantation Pathology;MacSween's Pathology of the Liver;2024

3. Significant Reduction in Posttransplant Hepatocellular Carcinoma Recurrence in the Post 6-Mo Waiting Policy Era;Transplantation;2023-11-13

4. Association of Karnofsky Performance Status with liver transplant outcomes in hepatocellular carcinoma;2022-11-07

5. Reduced Rates of Post-Transplant Recurrent Hepatocellular Carcinoma in Non-Alcoholic Steatohepatitis: A Propensity Score Matched Analysis;Transplant International;2022-07-05